Legal & General Group’s Indivior Pharmaceuticals INDV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.88M Sell
291,344
-16,306
-5% -$539K ﹤0.01% 1178
2025
Q4
$10.8M Buy
307,650
+172,129
+127% +$5.26M ﹤0.01% 1126
2025
Q3
$2.74M Sell
135,521
-512,042
-79% -$10.7M ﹤0.01% 1853
2025
Q2
$9.5M Sell
647,563
-117,849
-15% -$1.37M ﹤0.01% 1219
2025
Q1
$7.18M Buy
765,412
+49,492
+7% +$520K ﹤0.01% 1323
2024
Q4
$9.18M Buy
715,920
+19,542
+3% +$201K ﹤0.01% 1225
2024
Q3
$6.88M Sell
696,378
-236,574
-25% -$2.77M ﹤0.01% 1407
2024
Q2
$14.6M Buy
932,952
+919,745
+6,964% +$16.6M ﹤0.01% 943
2024
Q1
$283K Buy
13,207
+280
+2% +$5.26K ﹤0.01% 2622
2023
Q4
$195K Buy
12,927
+7,919
+158% +$141K ﹤0.01% 2703
2023
Q3
$109K Buy
+5,008
New +$114K ﹤0.01% 2820

Other funds holding INDV